Multiple Sclerosis Trial, Recruiting (NCT07304375)

Multiple Sclerosis Trial, Recruiting NCT07304375 Sponsor: Zealand University Hospital Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07304375 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 70 years old who have been diagnosed with early relapsing-remitting MS and are considered mentally capable of consenting to the trial
People whose MS-related disability falls within a specific moderate range, as measured by a standard MS disability scale called the EDSS (scores between 1 and 4.5)
People who have at least near-full muscle strength in their dominant hand, as measured by a standard muscle strength scale

Who may not be able to join:

People who have an implanted medical device in their body, such as a pacemaker or nerve stimulator
People who have epilepsy or a condition affecting the muscles or nerves (neuromuscular disease)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martin Ballegaard, Zealand University Hospital - Roskilde

Phone: +45 46323200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07304375

Sponsor: Zealand University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +45 46323200

More information: https://clinicaltrials.gov/study/NCT07304375

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 70 years old who have been diagnosed with early relapsing-remitting MS and are considered mentally capable of consenting to the trial
People whose MS-related disability falls within a specific moderate range, as measured by a standard MS disability scale called the EDSS (scores between 1 and 4.5)
People who have at least near-full muscle strength in their dominant hand, as measured by a standard muscle strength scale

Who may not be able to join:

People who have an implanted medical device in their body, such as a pacemaker or nerve stimulator
People who have epilepsy or a condition affecting the muscles or nerves (neuromuscular disease)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Zealand University Hospital

Registry

ClinicalTrials.gov

Start date

1 December 2025

Est. completion

30 August 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Motor/Skill Learning; Neurophysiological Measurement I - Cortical Activity; Neurophysiological Measurement II - Muscular Activity; Neurophysiological Measurement III - Corticocortical Functional Connectivity; Neurophysiological Measurement IV - Corticomuscular Functional Connectivity; Neurophysiological Measurement V - Muscular Functional Connectivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov